WHITEHAWK THERAPEUTICS, INC. Selling, General and Administrative Expense
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Selling, General and Administrative Expense of $5.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $5.22M, a 12.19% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $6.29M, a 50.92% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $5.87M, a 46.92% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $5.20M, a 27.62% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2025 was $29.82M, a 18.85% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2024 was $36.75M, a 17.51% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2023 was $44.55M, a 10.88% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2022 was $40.18M, a 117.04% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.22M 10-Q · filed 2026-08-06 | $11.51M 10-Q · filed 2026-08-06 | $17.37M derived: sum of 3 quarters · filed 2026-08-06 | $22.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $6.29M 10-Q · filed 2026-05-07 | $12.16M derived: sum of 2 quarters · filed 2026-05-07 | $17.36M derived: sum of 3 quarters · filed 2026-05-07 | $23.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $5.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $11.07M derived: sum of 2 quarters · filed 2026-03-12 | $17.01M derived: sum of 3 quarters · filed 2026-08-06 | $29.82M 10-K · filed 2026-03-12 |
| 2025-09-30 | $5.20M 10-Q · filed 2025-11-06 | $11.14M derived: sum of 2 quarters · filed 2026-08-06 | $23.96M 10-Q · filed 2025-11-06 | $35.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $5.94M 10-Q · filed 2026-08-06 | $18.75M 10-Q · filed 2026-08-06 | $29.81M derived: sum of 3 quarters · filed 2026-08-06 | $36.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $12.81M 10-Q · filed 2026-05-07 | $23.87M derived: sum of 2 quarters · filed 2026-05-07 | $31.05M derived: sum of 3 quarters · filed 2026-05-07 | $38.94M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $11.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $18.24M derived: sum of 2 quarters · filed 2026-03-12 | $26.13M derived: sum of 3 quarters · filed 2026-03-12 | $36.75M 10-K · filed 2026-03-12 |
| 2024-09-30 | $7.19M 10-Q · filed 2025-11-06 | $15.08M derived: sum of 2 quarters · filed 2025-11-06 | $25.70M 10-Q · filed 2025-11-06 | $36.04M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $7.89M 10-Q · filed 2025-08-07 | $18.51M 10-Q · filed 2025-08-07 | $28.86M derived: sum of 3 quarters · filed 2025-08-07 | $40.08M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $10.62M 10-Q · filed 2025-05-08 | $20.96M derived: sum of 2 quarters · filed 2025-05-08 | $32.19M derived: sum of 3 quarters · filed 2025-05-08 | $43.96M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $10.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $21.57M derived: sum of 2 quarters · filed 2025-03-28 | $33.34M derived: sum of 3 quarters · filed 2025-03-28 | $44.55M 10-K · filed 2025-03-28 |
| 2023-09-30 | $11.22M 10-Q · filed 2024-11-06 | $23.00M derived: sum of 2 quarters · filed 2024-11-06 | $34.20M 10-Q · filed 2024-11-06 | $45.31M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $11.78M 10-Q · filed 2024-08-07 | $22.98M 10-Q · filed 2024-08-07 | $34.09M derived: sum of 3 quarters · filed 2024-08-07 | $44.01M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $11.21M 10-Q · filed 2024-05-08 | $22.31M derived: sum of 2 quarters · filed 2024-05-08 | $32.23M derived: sum of 3 quarters · filed 2024-05-08 | $42.23M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $11.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $21.02M derived: sum of 2 quarters · filed 2024-03-13 | $31.03M derived: sum of 3 quarters · filed 2024-03-13 | $40.18M 10-K · filed 2024-03-13 |
| 2022-09-30 | $9.91M 10-Q · filed 2023-11-08 | $19.92M derived: sum of 2 quarters · filed 2023-11-08 | $29.07M 10-Q · filed 2023-11-08 | $38.79M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $10.01M 10-Q · filed 2023-08-09 | $19.15M 10-Q · filed 2023-08-09 | $28.87M derived: sum of 3 quarters · filed 2023-08-09 | $36.27M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $9.15M 10-Q · filed 2023-05-10 | $18.87M derived: sum of 2 quarters · filed 2023-05-10 | $26.27M derived: sum of 3 quarters · filed 2023-05-10 | $27.10M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $9.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $17.12M derived: sum of 2 quarters · filed 2023-03-29 | $17.95M derived: sum of 3 quarters · filed 2023-03-29 | $18.51M 10-K · filed 2023-03-29 |
| 2021-09-30 | $7.40M 10-Q · filed 2022-11-09 | $8.23M derived: sum of 2 quarters · filed 2022-11-09 | $8.79M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $830.00K 10-Q · filed 2022-08-10 | $1.39M 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $563.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |